Ank Reumer, Ph.D., Nelson Labs Europe - Qepler Summits And Conferences

Ank Reumer, Ph.D.

Study Director Pharma Services
Nelson Labs Europe
Leuven, Belgium
We are a leading, global testing lab specializing in expert advisory and testing solutions for medical device, pharmaceutical, tissue & biologics companies

Ank Reumer received her Ph.D. from the Faculty of Sciences at the University of Leuven (Belgium).

As a PostDoc at the Mass Spectrometry Facility of Leuven, she developed methods for peptide biomarker discovery.

In 2014 she started working at Nelson Labs. Currently she is senior Study Director in the Pharma Services team.

The main focus of this group is identifying organic impurities in drug products as well as in use stability testing of drug-device combinations and stability testing of Drug Products.

In addition, she is in charge of a project for developing methods to analyze protein-leachables interactions.

Related Sessions:

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 2: Friday, 12 April 2019
BLOCK:
CASE STUDY: Interactions of Leachables with Biopharmaceuticals: Combined In-Silico and Experimental Model to Monitor the Potential Impact on Quality and Safety of Therapeutic Proteins.
  • The potential effect of Leachables on the quality and the efficacy of Biopharmaceuticals by chemically modifying the therapeutic protein/peptide product.
  • Impact on the patient’s safety including immunogenicity (as a secondary safety effect of those interactions).
  • How to assess the reactivity of potential leachables
    • Nelson REACT: an in-silico reactivity approach to predict if any of the observed extractables could lead to a chemical interaction.
    • Chemical reactivity tests to actually screen for residual chemical reactivity as predicted by Nelson REACT.
  • Case studies
View Details